Tyson Foods' Q2 profit surges, but revenue disappoints amid challenges in beef and pork segments.
Trump signs executive actions to boost domestic drug manufacturing and tighten oversight on gain-of-function research, raising concerns over potential higher costs and shortages.
Tyson Foods' Q2 profit surges, but revenue disappoints amid challenges in beef and pork segments.
Trump signs executive actions to boost domestic drug manufacturing and tighten oversight on gain-of-function research, raising concerns over potential higher costs and shortages.